GlassScriptPhysician profile
Elizabeth M Perry
NPI 1932168937
$907.77
in general payments reported to CMS, 2019-2025
20 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $55.45 · 2021: $134 · 2022: $45.10 · 2023: $217 · 2024: $169 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $163.40 | 2019-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $118.12 | 2021-2025 | |
| Pfizer INC. | $76.45 | 2021-2024 | |
| Boston Scientific Corporation | $71.80 | 2025 | Wavewriter Alpha Prime 16 |
| Lilly USA, LLC | $63.80 | 2019-2024 | Jardiance, Zepbound |
| Amgen INC. | $56.37 | 2019-2025 | Evenity, Repatha, Otezla |
| Abbott Laboratories | $49.94 | 2024-2025 | Freestyle Libre 3 |
| Baxter Healthcare | $49.61 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $48.33 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $36.35 | 2020-2021 | |
| Eisai INC. | $24.03 | 2019 | |
| Zimmer Biomet Holdings, INC. | $21.68 | 2025 | Persona |
| Modernatx, INC. | $20.56 | 2024 | Moderna Covid-19 Vaccine |
| Daiichi Sankyo INC. | $17.88 | 2023 | Injectafer |
| Gilead Sciences, INC. | $17.38 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.81 | 2023 | Shingrix, Arexvy |
| Tactile Systems Technology INC | $14.91 | 2024 | Flexitouch Plus, Entre Plus |
| Sunovion Pharmaceuticals INC. | $14.74 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.91 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.